Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes

The epigenetic modifier EZH2 is part of the polycomb repressive complex that suppresses gene expression via histone methylation. Activating mutations in EZH2 are found in a subset of melanoma that contributes to disease progression by inactivating tumor suppressor genes. In this study we have target...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Tiffen, Jessamy C., Gunatilake, Dilini, Gallagher, Stuart J., Gowrishankar, Kavitha, Heinemann, Anja, Cullinane, Carleen, Dutton-Regester, Ken, Pupo, Gulietta M., Strbenac, Dario, Yang, Jean Y., Madore, Jason, Mann, Graham J., Hayward, Nicholas K., McArthur, Grant A., Filipp, Fabian V., Hersey, Peter
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2015
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4694971/
https://ncbi.nlm.nih.gov/pubmed/26304929
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars